Pradžia › Virškinimo ligos › Florida
Virškinimo ligos klinikiniai tyrimai Florida
6 tyrimai dėl Virškinimo ligos ieško dalyvių vietose Florida.
Miestai Florida
- Sarasota5 tyrimai
- Jacksonville5 tyrimai
- Tampa3 tyrimai
- Town 'n' Country3 tyrimai
- Miami3 tyrimai
- Cape Coral3 tyrimai
- Orlando3 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- James A. Haley Veterans Hospital, Tampa
Renkami dalyviai
Amžius nuo 65 iki 82 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05612347A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Novum Research, LLC, Clermont
- I.V.A.M. Clinical & Investigational Center, LLC, Doral
- Florida Research Institute, Lakewood Rch
- ir dar 9
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06598943Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Florida Cancer Specialists, Bonita Springs
- Florida Cancer Specialists, Bradenton
- Comprehensive Hematology Oncology, Brandon
- ir dar 19
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07222800Product Surveillance Registry
- Bradenton
- Clearwater
- Davie
- ir dar 7
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-18 · NCT01524276A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Brandon
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- ir dar 15
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- 89bio Clinical Study Site, Gainesville
- ir dar 15
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06419374Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.